Research graph
References from A phase 2 study of radiosurgery and temozolomide for patients with 1 to 4 brain metastases. Local targets link to admitted publications; unresolved targets remain external evidence.
The management of brain metastases
10.1016/s0305-7372(03)00105-1 · 2003 · External reference
Radiosurgery plus whole-brain radiation therapy for brain metastases
10.1001/jama.296.17.2089 · 2006 · External reference
Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial
10.1001/jama.295.21.2483 · 2006 · External reference
A phase II trial of temozolomide for patients with recurrent or progressive brain metastases
10.1023/a:1012226718323 · 2001 · External reference
Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases
10.1200/jco.2002.04.140 · 2002 · External reference
Effect of temozolomide on central nervous system relapse in patients with advanced melanoma
10.1097/00008390-200204000-00011 · 2002 · External reference
The role of prophylactic anticonvulsants in the management of brain metastases: A systematic review and evidence-based clinical practice guideline
10.1007/s11060-009-0056-5 · 2010 · External reference
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone
10.1016/j.ijrobp.2007.05.084 · 2008 · External reference
Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: Final report of RTOG protocol 90-05
10.1016/s0360-3016(99)00507-6 · 2000 · External reference
First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
10.1186/s13104-015-1153-5 · 2015 · External reference
Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy
10.3390/ijms15046910 · 2014 · External reference
Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: Results and implications
10.1016/s0360-3016(01)02645-1 · 2002 · External reference
Recursive partitioning analysis classifications I and II: Applicability evaluated in a randomized trial for resected single brain metastases
10.1097/01.coc.0000135379.36325.de · 2004 · External reference
Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: Results of Radiation Therapy Oncology Group trial BR-0018
10.1016/j.ijrobp.2003.09.023 · 2004 · External reference
Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function
10.1200/jco.2006.09.2536 · 2007 · External reference
Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: Results of a phase III trial
10.1016/j.ijrobp.2008.05.068 · 2009 · External reference
The role of chemotherapy in the management of newly diagnosed brain metastases: A systematic review and evidence-based clinical practice guideline
10.1007/s11060-009-0062-7 · 2010 · External reference
